HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
HYTN Innovations Inc.'s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.
National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (CSE:EMH).
Subsequently, Emerald announced a change in business strategy that would result in the winding down of all cannabis related activities, including its partnership with HYTN.
HYTN's receipt of the license amendment ensures that it can continue to sell its all-natural, sugar and calorie-free sparkling cannabis beverages across Canada.
"Achieving this milestone under a strict timeline was a monumental feat lead by our exceptional operations team," Jason Broome, HYTN's chief operations officer, said. "This amendment coupled with the strong demand we have already seen will allow HYTN to execute on its sales objectives."
"Emerald's decision to pivot out of cannabis accelerated our plan and timeline to achieve the license amendment," HYTN CEO, Elliot McKerr, commented. "We are now well positioned to recapture the 13.5% margin contribution previously associated with our agreement with Emerald."
The company noted that plans are now in place to ensure a smooth transition for all existing customers.
Photo: Courtesy of Tim Foster on Unsplash
HYTN Innovations Inc.'s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.
HYTN创新公司的(CSE：HYTN)子公司HYTN大麻公司vt.，有加拿大卫生部批准了一项许可证修正案，允许向省和地区授权的零售商销售大麻提取物、食用大麻和大麻局部产品。
National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (CSE:EMH).
通过与Emerald Health Treeutics Inc.的合作协议，HYTN注入大麻的起泡饮料已经开始在全国销售。(TSXV：EMH)(OTCQX：EMHTF)(CSE：EMH)。
Subsequently, Emerald announced a change in business strategy that would result in the winding down of all cannabis related activities, including its partnership with HYTN.
后来，Emerald宣布改变商业战略，将导致所有与大麻相关的活动逐步结束，包括与HYTN的合作伙伴关系。
HYTN's receipt of the license amendment ensures that it can continue to sell its all-natural, sugar and calorie-free sparkling cannabis beverages across Canada.
HYTN收到许可证修正案，确保其可以继续在加拿大各地销售其全天然、无糖和无卡路里的起泡大麻饮料。
"Achieving this milestone under a strict timeline was a monumental feat lead by our exceptional operations team," Jason Broome, HYTN's chief operations officer, said. "This amendment coupled with the strong demand we have already seen will allow HYTN to execute on its sales objectives."
在严格的时间表下实现这一里程碑是我们卓越的运营团队领导的一项不朽的壮举。“HYTN首席运营官杰森·布鲁姆(Jason Broome)说。“这项修订，加上我们已经看到的强劲需求，将使和记黄埔能够实现其销售目标。”
"Emerald's decision to pivot out of cannabis accelerated our plan and timeline to achieve the license amendment," HYTN CEO, Elliot McKerr, commented. "We are now well positioned to recapture the 13.5% margin contribution previously associated with our agreement with Emerald."
“Emerald戒除大麻的决定加快了我们实现许可证修正案的计划和时间表。”HYTN首席执行官埃利奥特·麦克尔，评论说。我们现在处于有利地位，可以重新获得之前与Emerald达成的协议所带来的13.5%的利润率。“
The company noted that plans are now in place to ensure a smooth transition for all existing customers.
该公司指出，现在已经制定了计划，以确保所有现有客户的平稳过渡。
Photo: Courtesy of Tim Foster on Unsplash
图片来源：Unspash上的蒂姆·福斯特(Tim Foster)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧